期刊文献+

取消第三类医疗技术准入审批的做法 被引量:3

Innovation and Management of Third Type of Medical Approaches After Administrative Approval Cancelled
下载PDF
导出
摘要 2015年5月14日,国家卫计委印发"取消第三类医疗技术临床应用准入审批"通知,明确禁止和限制临床应用的第三类医疗技术项目的范围,强调医疗机构承担主体责任,加强事中事后监管工作。对第三类医疗技术审批取消后的相关法律法规缺位、后续实践中伦理委员会的作用和动态管理、再评价综合管理模式等未明确规定的问题进行探讨。 The approval of clinical application of third type medical approaches was cancelled in the notification delivered by the national health and family planning commission in May 14 nd,2015. The notification reaffirmed the forbidden or restrained scopes of clinical application of third type medical approaches,the hospital's responsibility and administrative supervision all the times. The aim of this study is to probe into the related laws and regulations,the roles of ethics committee,and integrated management after the cancellation of the approval of clinical application of third type medical approaches.
机构地区 解放军第
出处 《解放军医院管理杂志》 2016年第3期280-282,共3页 Hospital Administration Journal of Chinese People's Liberation Army
关键词 第三类医疗技术 准入审批 监管 the third type of medical approaches adminstrative approval supervision
  • 相关文献

参考文献6

二级参考文献89

  • 1田冬霞,张金钟.中国医学伦理委员会研究进展[J].中国医学伦理学,2006,19(1):78-81. 被引量:31
  • 2O’Neill DW,Adams S,Bhardwaj N.Manipulating dendritic cellbiology for the active immunotherapy of cancer[J].Blood,2004,104(8):2235-2246.
  • 3Tacken PJ,de Vries IJ,Torensma R,et al.Dendritic-cell immu-notherapy:From ex vivo loading to in vivo targeting[J].Nat RevImmunol,2007,7(10):790-802.
  • 4Hsu FJ,Benike C,Fagnoni F,et al.Vaccination of patients withB-cell lymphoma using autologous antigen-pulsed dendritic cells[J].Nat Med,1996,2(1):52-58.
  • 5DeFrancesco L.Landmark approval for Dendreon’s cancer vaccine[J].Nat Biotechnol,2010,28(6):531-532.
  • 6Higano1 CS,Small EJ,Schellhammer P,et al.Sipuleucel-T[J].Nat Rev Drug Discov,2010,9(7):513-514.
  • 7Ledford H.A shot in the arm for cancer vaccines?[J].Nature,2010,464(7292):1110-1111.
  • 8Hodi FS,O'Day SJ,McDermott DF,et al.Improved survival withipilimumab in patients with metastatic melanoma[J].N Engl JMed,2010,363(8):711-723.
  • 9Gulley JL,Madan RA,Schlom J.Impact of tumour volume on thepotential efficacy of therapeutic vaccines[J].Curr Oncol,2011,18(3):e150-157.
  • 10Drake CG.Prostate cancer as a model for tumour immunotherapy[J].Nat Rev Immunol,2010,10(8):580-593.

共引文献37

同被引文献37

引证文献3

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部